Companies/Securities in Focus
RPH : RATCHAPHRUEK HOSPITAL PUBLIC COMPANY LIMITED
|
Company Name
RATCHAPHRUEK HOSPITAL PUBLIC COMPANY LIMITED
Address
456 Moo14, Mittraphap Rd., Muang Khon Kaen
Telephone
0-4333-3555
Fax
-
Website
Financial Statement
|
|
Trading Statistics (as of 03 Aug 2021)
P/E
46.06
Dvd. Yield(%)
1.86
P/BV
2.78
Market Cap. (M. Baht)
3,822.00
|
|
Market
SET
Industry
Services
Sector
Health Care Services
First Trade Date
27 Feb 2017
Capital Detail
Par Value
1.00 Baht
Common Stock
Authorized Capital
546,000,000.00 Baht
Paid-up Capital
546,000,000.00 Baht
Preferred Stock
Authorized Capital
-
Paid-up Capital
-
Foreign Limit
49.00000 %
(as of 03/08/2021) ISIN Number
Local
TH7757010007
Foreign
TH7757010015
NVDR
TH7757010R16
Fiscal End
31/12
Company Auditor (Effective Until 31/12/2021)
The person taking the highest responsibility in finance and accounting
Mr. Chatsiam Jariyawattanagulgit (Starting Date 01/06/2007)
The person supervising accounting
Miss Supaporn Sukhee (Starting Date 01/06/2012)
|
|
Shares Detail
Common Stock
Listed Share
546,000,000 Shares
Paid-up Stock
546,000,000 Shares
Voting Right Ratio
1 : 1
Treasury Stock
-
Voting Stock minus Treasury Stock
as of 04 Aug 2021
546,000,000 Shares
as of 31 Jul 2021
546,000,000 Shares
Preferred Stock
Listed Share
-
Treasury Stock
-
Voting Stock minus Treasury Stock
as of 04 Aug 2021
-
as of 31 Jul 2021
-
|
|
Dividend Policy
40% of the net profit after tax and required provisions. Nonetheless, the Company?s payout may deviate from the policy, depending on its operating performance, business expansion plans, liquidity and other circumstances (with additional conditions)
|
|
Latest Board
Board of Directors
Position
Mr. SUTHON SRIYAPUN
PRESIDENT
Mr. TEERAWAT SRINAKARIN
CHIEF EXECUTIVE OFFICER
DIRECTOR
Mr. VALLOP LAOPAIBOON
VICE PRESIDENT
Mr. SRICHAI KRUSUN
DIRECTOR
Mr. SUPHAN SRITHAMMA
DIRECTOR
Mr. SARAN SUPAKSARAN
INDEPENDENT DIRECTOR
CHAIRMAN OF THE AUDIT COMMITTEE
Mr. TEERASAK NARANONG
INDEPENDENT DIRECTOR
AUDIT COMMITTEE
Mr. VORATHEP RANGCHAIKUL
INDEPENDENT DIRECTOR
AUDIT COMMITTEE
|
Remark
• For foreign listed company (Secondary Listing), P/E P/BV and Dividend Yield are calculated by applying BOT exchange rates for comparison purpose only.
• For foreign listed company (Secondary Listing), P/E P/BV and Dividend Yield are calculated by applying BOT exchange rates for comparison purpose only.
